Even though injectable vials of insulin have been around for nearly a century, and synthetic insulin for almost 40 years, there is no generic form of the vital diabetes medication. In recent years, the price of insulin has risen sharply, leaving healthcare providers with concerns about patients who can’t afford insulin skipping doses and risking lost limbs and eyesight. Pharma giant Eli Lilly — maker of popular insulin brands Humalog, Humulin, and Basaglar — is now proposing a solution that it believes could make the medication more affordable — but only for some people. [More]
Earlier this week, we shared the concerns of patients who are struggling with the rising cost of EpiPens, injection devices that can save lives in the case of a severe allergic reaction to foods or other substances. The important thing about EpiPens, though, is that patients hope to never actually need to use them. Another drug with significant recent price increases, insulin, has to be taken every day… when patients can afford it. [More]
The ever-vigilant Transportation Security Administration has kept the air safe from harmless fluids by confiscating a pregnant traveler’s insulin and ice packs as she tried to board a flight from Denver to Phoenix last week.